Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Role of capsule endoscopy in suspected celiac disease: A European multi-centre study.

Tytuł:
Role of capsule endoscopy in suspected celiac disease: A European multi-centre study.
Autorzy:
Luján-Sanchis M; Marisol Luján-Sanchis, Javier Sempere-García-Argüelles, Digestive Diseases Unit, General University Hospital of Valencia, 46026 Valencia, Spain.
Pérez-Cuadrado-Robles E; Marisol Luján-Sanchis, Javier Sempere-García-Argüelles, Digestive Diseases Unit, General University Hospital of Valencia, 46026 Valencia, Spain.
García-Lledó J; Marisol Luján-Sanchis, Javier Sempere-García-Argüelles, Digestive Diseases Unit, General University Hospital of Valencia, 46026 Valencia, Spain.
Juanmartiñena Fernández JF; Marisol Luján-Sanchis, Javier Sempere-García-Argüelles, Digestive Diseases Unit, General University Hospital of Valencia, 46026 Valencia, Spain.
Elli L; Marisol Luján-Sanchis, Javier Sempere-García-Argüelles, Digestive Diseases Unit, General University Hospital of Valencia, 46026 Valencia, Spain.
Jiménez-García VA; Marisol Luján-Sanchis, Javier Sempere-García-Argüelles, Digestive Diseases Unit, General University Hospital of Valencia, 46026 Valencia, Spain.
Egea-Valenzuela J; Marisol Luján-Sanchis, Javier Sempere-García-Argüelles, Digestive Diseases Unit, General University Hospital of Valencia, 46026 Valencia, Spain.
Valle-Muñoz J; Marisol Luján-Sanchis, Javier Sempere-García-Argüelles, Digestive Diseases Unit, General University Hospital of Valencia, 46026 Valencia, Spain.
Carretero-Ribón C; Marisol Luján-Sanchis, Javier Sempere-García-Argüelles, Digestive Diseases Unit, General University Hospital of Valencia, 46026 Valencia, Spain.
Fernández-Urién-Sainz I; Marisol Luján-Sanchis, Javier Sempere-García-Argüelles, Digestive Diseases Unit, General University Hospital of Valencia, 46026 Valencia, Spain.
López-Higueras A; Marisol Luján-Sanchis, Javier Sempere-García-Argüelles, Digestive Diseases Unit, General University Hospital of Valencia, 46026 Valencia, Spain.
Alonso-Lázaro N; Marisol Luján-Sanchis, Javier Sempere-García-Argüelles, Digestive Diseases Unit, General University Hospital of Valencia, 46026 Valencia, Spain.
Sanjuan-Acosta M; Marisol Luján-Sanchis, Javier Sempere-García-Argüelles, Digestive Diseases Unit, General University Hospital of Valencia, 46026 Valencia, Spain.
Sánchez-Ceballos F; Marisol Luján-Sanchis, Javier Sempere-García-Argüelles, Digestive Diseases Unit, General University Hospital of Valencia, 46026 Valencia, Spain.
Rosa B; Marisol Luján-Sanchis, Javier Sempere-García-Argüelles, Digestive Diseases Unit, General University Hospital of Valencia, 46026 Valencia, Spain.
González-Vázquez S; Marisol Luján-Sanchis, Javier Sempere-García-Argüelles, Digestive Diseases Unit, General University Hospital of Valencia, 46026 Valencia, Spain.
Branchi F; Marisol Luján-Sanchis, Javier Sempere-García-Argüelles, Digestive Diseases Unit, General University Hospital of Valencia, 46026 Valencia, Spain.
Ruano-Díaz L; Marisol Luján-Sanchis, Javier Sempere-García-Argüelles, Digestive Diseases Unit, General University Hospital of Valencia, 46026 Valencia, Spain.
Prieto-de-Frías C; Marisol Luján-Sanchis, Javier Sempere-García-Argüelles, Digestive Diseases Unit, General University Hospital of Valencia, 46026 Valencia, Spain.
Pons-Beltrán V; Marisol Luján-Sanchis, Javier Sempere-García-Argüelles, Digestive Diseases Unit, General University Hospital of Valencia, 46026 Valencia, Spain.
Borque-Barrera P; Marisol Luján-Sanchis, Javier Sempere-García-Argüelles, Digestive Diseases Unit, General University Hospital of Valencia, 46026 Valencia, Spain.
González-Suárez B; Marisol Luján-Sanchis, Javier Sempere-García-Argüelles, Digestive Diseases Unit, General University Hospital of Valencia, 46026 Valencia, Spain.
Xavier S; Marisol Luján-Sanchis, Javier Sempere-García-Argüelles, Digestive Diseases Unit, General University Hospital of Valencia, 46026 Valencia, Spain.
Argüelles-Arias F; Marisol Luján-Sanchis, Javier Sempere-García-Argüelles, Digestive Diseases Unit, General University Hospital of Valencia, 46026 Valencia, Spain.
Herrerías-Gutiérrez JM; Marisol Luján-Sanchis, Javier Sempere-García-Argüelles, Digestive Diseases Unit, General University Hospital of Valencia, 46026 Valencia, Spain.
Pérez-Cuadrado-Martínez E; Marisol Luján-Sanchis, Javier Sempere-García-Argüelles, Digestive Diseases Unit, General University Hospital of Valencia, 46026 Valencia, Spain.
Sempere-García-Argüelles J; Marisol Luján-Sanchis, Javier Sempere-García-Argüelles, Digestive Diseases Unit, General University Hospital of Valencia, 46026 Valencia, Spain.
Źródło:
World journal of gastroenterology [World J Gastroenterol] 2017 Jan 28; Vol. 23 (4), pp. 703-711.
Typ publikacji:
Journal Article; Multicenter Study; Observational Study
Język:
English
Imprint Name(s):
Publication: 2014- : Pleasanton, CA : Baishideng Publishing Group
Original Publication: Beijing : WJG Press, c1998-
MeSH Terms:
Capsule Endoscopy*
Gastroscopy*
Celiac Disease/*diagnostic imaging
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Atrophy ; Child ; Diet, Gluten-Free ; Europe ; Female ; Humans ; Male ; Middle Aged ; Patient Safety ; Prevalence ; Retrospective Studies ; Young Adult
References:
Gastrointest Endosc. 2013 Feb;77(2):227-32. (PMID: 23200728)
J Laparoendosc Adv Surg Tech A. 2009 Dec;19(6):815-20. (PMID: 19405806)
Eur J Gastroenterol Hepatol. 2012 Mar;24(3):303-8. (PMID: 22266837)
BMC Gastroenterol. 2012 Jul 19;12:90. (PMID: 22812595)
Gastrointest Endosc. 2011 Dec;74(6):1315-22. (PMID: 21835400)
Nutrients. 2016 Feb 08;8(2):84. (PMID: 26867199)
Gastrointest Endosc. 2013 Dec;78(6):805-15. (PMID: 24119509)
Dig Dis Sci. 2009 Jun;54(6):1280-3. (PMID: 18975089)
Am J Gastroenterol. 2012 Oct;107(10):1546-53. (PMID: 22964554)
Clin Gastroenterol Hepatol. 2008 Feb;6(2):186-93; quiz 125. (PMID: 18096440)
Clin Gastroenterol Hepatol. 2015 Aug;13(8):1396-404; quiz e127-9. (PMID: 25051511)
Nutrients. 2015 Sep 08;7(9):7486-504. (PMID: 26371035)
Endoscopy. 2015 Apr;47(4):352-76. (PMID: 25826168)
World J Gastroenterol. 2008 Jul 14;14(26):4146-51. (PMID: 18636659)
Gastroenterol Hepatol Bed Bench. 2015 Spring;8(2):110-6. (PMID: 25926935)
Comput Biol Med. 2015 Oct 1;65:315-9. (PMID: 26293571)
Can J Gastroenterol. 2004 Jan;18(1):25-8. (PMID: 14760428)
J Clin Gastroenterol. 2003 Mar;36(3):219-21. (PMID: 12590232)
Am J Gastroenterol. 2011 Oct;106(10):1837-742. (PMID: 21606978)
Am J Gastroenterol. 2013 May;108(5):656-76; quiz 677. (PMID: 23609613)
Nutrients. 2015 Jun 18;7(6):4966-77. (PMID: 26096570)
Clin Gastroenterol Hepatol. 2013 Mar;11(3):259-61. (PMID: 23142601)
BMC Med. 2012 Feb 07;10:13. (PMID: 22313950)
Ann Med. 2010 Dec;42(8):587-95. (PMID: 21070098)
Gut. 2014 Aug;63(8):1210-28. (PMID: 24917550)
Am J Gastroenterol. 2007 Aug;102(8):1624-31. (PMID: 17459022)
Gastroenterol Hepatol Bed Bench. 2012 Winter;5(Suppl 1):S1-7. (PMID: 24834231)
Expert Rev Gastroenterol Hepatol. 2010 Feb;4(1):31-5. (PMID: 20136587)
Comput Biol Med. 2015 Oct 1;65:331-2. (PMID: 26361339)
Gastroenterol Hepatol Bed Bench. 2015 Spring;8(2):171-7. (PMID: 25926944)
Contributed Indexing:
Keywords: Anti-transglutaminase antibodies; Capsule endoscopy; Celiac disease; Gluten-free diet; Non-celiac gluten sensitivity
Entry Date(s):
Date Created: 20170221 Date Completed: 20170814 Latest Revision: 20181113
Update Code:
20240105
PubMed Central ID:
PMC5292345
DOI:
10.3748/wjg.v23.i4.703
PMID:
28216978
Czasopismo naukowe
Aim: To analyze the diagnostic yield (DY), therapeutic impact (TI) and safety of capsule endoscopy (CE).
Methods: This is a multi-centre, observational, analytical, retrospective study. A total of 163 patients with suspicion of celiac disease (CD) (mean age = 46.4 ± 17.3 years, 68.1% women) who underwent CE from 2003 to 2015 were included. Patients were divided into four groups: seronegative CD with atrophy (Group-I, n = 19), seropositive CD without atrophy (Group-II, n = 39), contraindication to gastroscopy (Group-III, n = 6), seronegative CD without atrophy, but with a compatible context (Group-IV, n = 99). DY, TI and the safety of CE were analysed.
Results: The overall DY was 54% and the final diagnosis was villous atrophy ( n = 65, 39.9%), complicated CD ( n = 12, 7.4%) and other enteropathies ( n = 11, 6.8%; 8 Crohn's). DY for groups I to IV was 73.7%, 69.2%, 50% and 44.4%, respectively. Atrophy was located in duodenum in 24 cases (36.9%), diffuse in 19 (29.2%), jejunal in 11 (16.9%), and patchy in 10 cases (15.4%). Factors associated with a greater DY were positive serology (68.3% vs 49.2%, P = 0.034) and older age ( P = 0.008). On the other hand, neither sex nor clinical presentation, family background, positive histology or HLA status were associated with DY. CE results changed the therapeutic approach in 71.8% of the cases. Atrophy was associated with a greater TI (92.3% vs 45.3%, P < 0.001) and 81.9% of the patients responded to diet. There was one case of capsule retention (0.6%). Agreement between CE findings and subsequent histology was 100% for diagnosing normal/other conditions, 70% for suspected CD and 50% for complicated CD.
Conclusion: CE has a high DY in cases of suspicion of CD and it leads to changes in the clinical course of the disease. CE is safe procedure with a high degree of concordance with histology and it helps in the differential diagnosis of CD.
Competing Interests: Conflict-of-interest statement: No potential conflicts of interest relevant to this article were reported.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies